We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The cornerstone of Merck’s defense against the 11,500 lawsuits filed by former patients who claim the drug caused heart attacks and strokes — that the health risks associated with the drug began in patients after taking the drug for 18 months — has been further eroded by a correction to a key scientific study.